PMGC Holdings Inc. (ELAB)
NASDAQ·Healthcare·Biotechnology
$2.56
+0.59%
Mkt Cap $72.92K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | $304.14K | — | — | -$0.52 | — | — | — |
| Q4 2025 Nov 14, 2025 | — | $285.95K | — | — | -$19.80 | — | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | — | -$6.44 | — | — | — |
| Q2 2025 May 14, 2025 | — | — | — | — | -$40.60 | — | — | — |
| Q2 2025 Apr 4, 2025 | — | -$1.75M | — | — | -$99.99 | — | — | — |
| Q4 2024 Nov 13, 2024 | — | $527.48K | — | — | -$1371.66 | — | — | — |
| Q3 2024 Aug 14, 2024 | — | $605.53K | — | — | -$1567.61 | — | — | — |
| Q2 2024 May 15, 2024 | — | $614.56K | — | — | -$1567.61 | — | — | — |
| Q1 2024 Mar 29, 2024 | — | $698.59K | — | — | -$1567.61 | — | — | — |
| Q4 2023 Dec 11, 2023 | — | $554.65K | — | — | -$0.08 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $316.53K | — | — | -$22.55 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $142.82K | — | — | -$19.04 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $138.90K | — | — | -$5.73 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $432.12K | — | — | -$4.40 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $170.46K | — | — | -$0.40 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $24.79K | — | — | -$0.91 | — | — | — |